SCHEMBL21052503

SCHEMBL21052503

Nc1cc(Br)c(Cl)cc1CC=O

nearest known ligand 0.36

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
AHR P35869 2/20 0.36
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31
GAA P10253 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4591472 0.84 GAA (0.40) CA1CA2CA9GAA
SCHEMBL15067721 0.78 KDM1A (0.33) CA1CA2CA9
SCHEMBL3467798 0.78 CA1 (0.31) CA1CA2CA9GAA
SCHEMBL15320818 0.78 ANO1 (0.35) AHR
SCHEMBL27749404 0.77 ALDH1A1 (0.32)
SCHEMBL29384228 0.76 AHR (0.32) AHR
SCHEMBL21356184 0.76 AHR (0.32) AHR
SCHEMBL17601428 0.75 AHR (0.40) AHRCA1CA2CA9GAA
SCHEMBL17601206 0.71 ERN1 (0.41) AHRCA1CA2CA9GAA
SCHEMBL6739825 0.71 KDM4E (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019110751-A1 TETRACYCLIC COMPOUNDS AS INHIBITORS OF G12C MUTANT RAS PROTEIN, FOR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2019-06-13 WO disclosed